Drug Prices | Arnold Ventures

Three Issues That Plague the Drug Pricing System — and the Evidence That Can Shape Solutions

Charity Prescription Drug Programs Can Hurt Rather Than Help, Study Shows

Pill bottles

What Is an Inflationary Rebate, and How Can It Help Bring Down Drug Prices? Explainer

Cross-Border Drug Runs, Deadly Rationing and Black Market Sales Define Life of a Type 1 Diabetes Patient

An injection of insulin

New Study Addresses Vast Price Disparities Between Drugs in the U.S., Other Nations Q&A

Transparency is Just One Piece of the Drug Pricing Puzzle

Poll Reveals Near-Unanimous Call for Aggressive Congressional Action to Lower Prescription Drug Prices

Civica Rx Set to Deliver Essential Antibiotics to Hundreds of Hospitals

Arnold: ‘Independent Body, Not the Payer or Drug Company, Should Decide the Value of a Drug’

Drug Industry Patents Go Under Senate Judiciary Committee’s Microscope

Civica Rx Celebrates Milestone on Path to Stabilizing Supply of Generic Drugs

Drug Pricing Transparency Draws Ire of Lawmakers

Maryland at the Forefront of Groundbreaking Legislation to Lower Drug Prices

John Arnold: U.S. Needs to Regulate Prescription Drugs as a Product That's ‘Vital to Human Need’

Tuesday Offers Three Opportunities to Join the Conversation on Rising Health Costs

Louisiana One Step Closer to Breakthrough Approach in Hepatitis C Treatment

Policies to Speed Generics to Market Gain Momentum

Drug Pricing Debate Brings More Testimony from Experts, Patients

The Four Arguments You're Likely to Hear from Drug Executives

Prescription drugs

Required Reading for Tuesday's Showdown Between Drug Manufacturers, Lawmakers

‘I Deserve the Right to Live’: Key Takeaways from Ways and Means Hearing on Drug Prices

Trump’s 2019 State of the Union a Call for Bipartisanship on Health Care

Five Takeaways from the First Senate Hearing on Drug Pricing

'This Isn't Capitalism. This Is a Form of Oppression.'

More stories from:

Criminal Justice